Search Results 721-730 of 24232 for In situ

1. Dr. Joseph Murray Archives - Mayo Clinic News Network

   carcinoma in situ, which is considered to be the earliest form of breast cancer. And Katherine Zeratsky, a Mayo Clinic registered dietician nutritionist, will ...

2. A Study of TAS-120 in Patients with Advanced Solid Tumors - Mayo Clinic

   Local laboratory testing using next generation sequencing [NGS], fluorescence in situ hybridization [FISH], or other assays that can determine FGFR2 gene ...

3. A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label - Mayo Clinic

   A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated ...

4. LEGEND Study: A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients With BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients Who Are BCG Naïve or Received Incomplete BCG Treatment - Mayo Clinic

   BCG-unresponsive NMIBC with carcinoma in situ (CIS) with or without coexisting papillary Ta/T1 tumors who are ineligible for or have elected not to undergo ...

5. Pasireotide LAR in Severe Polycystic Liver Disease - Mayo Clinic

   ... in situ of uterine cervix. (Patients who have had no evidence of disease from primary cancer for 3 or more years are allowed to participate in the study.) ...

6. A Study Of Inhaled RVT-1601 For The Treatment Of Persistent Cough In Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   A Study Of Inhaled RVT-1601 For The Treatment Of Persistent Cough In Idiopathic Pulmonary Fibrosis (IPF) ... in situ). Current smoker (i.e., use of tobacco ...

7. A Global, Randomized, Placebo-controlled Phase 3 Study of Fruquintinib in Patients with Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Other malignancy, except for non-melanoma skin cancer, in situ cervical ca or bladder ca (Tis and T1) that have been adequately treated during the 5 years prior ...

8. Molecular Breast Imaging in Women with Atypia and LCIS - Mayo Clinic

   ... in women who have atypical ductal hyperplasia, atypical lobular hyperplasia, or lobular carcinoma in situ. Participation eligibility. Participant eligibility ...

9. Radiation Therapy, Paclitaxel, and Carboplatin with or without Trastuzumab in Treating Patients with Esophageal Cancer - Mayo Clinic

   Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in ... in situ of the breast, oral cavity, or cervix are permissible); Medical ...

10. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

    History of another primary malignancy except adequately treated in situ carcinoma of the cervix or non-melanoma carcinoma of the skin or any other ...